Search

Author/Creator Jain, P.

11. ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY. (17th June 2021)

Authors:
Wang, M.; Rule, S.; Zinzani, P. L.; Goy, A.; Casasnovas, O.; Smith, S. D.; Damaj, G.; Doorduijn, J. K.; Lamy, T.; Morschhauser, F.; Panizo, C.; Shah, B.; Davies, A.; Eek, R.; Dupuis, J.; Jacobsen, E.; Kater, A. P.; Le Gouill, S.; Oberic, L.; Robak, T.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study. (16th October 2020)

Authors:
Chin, C. K.; Lim, K. J.; Lewis, K.; Jain, P.; Qing, Y.; Feng, L.; Cheah, C. Y.; Seymour, J. F.; Ritchie, D.; Burbury, K.; Tam, C. S.; Fowler, N. H.; Fayad, L. E.; Westin, J. R.; Neelapu, S. S.; Hagemeister, F. B.; Samaniego, F.; Flowers, C. R.; Nastoupil, L. J.; Dickinson, M. J.
Journal:
British journal of haematology
Issue:
Volume 191:Number 5(2020)
Page Start:
806
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Beam acceleration through proton radio frequency quadrupole accelerator in BARC. (3rd May 2016)

Authors:
Bhagwat, P.V.; Krishnagopal, S.; Mathew, J.V.; Singh, S.K.; Jain, P.; Rao, S.V.L.S.; Pande, M.; Kumar, R.; Roychowdhury, P.; Kelwani, H.; Rao, B.V. Rama; Gupta, S.K.; Agarwal, A.; Kukreti, B.M.; Singh, P.
Journal:
Journal of instrumentation
Issue:
Volume 11:Number 5(2016:May)
Page Start:
T05001
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. COMBINATION OF IBRUTINIB WITH RITUXIMAB (IR) IS HIGHLY EFFECTIVE IN PREVIOUSLY UNTREATED ELDERLY (>65 YEARS) PATIENTS (PTS) WITH MANTLE CELL LYMPHOMA (MCL) – PHASE II TRIAL. (12th June 2019)

Authors:
Jain, P.; Romaguera, J.; Nomie, K.; Zhang, S.; Wang, L.; Oriabure, O.; Wagner‐Bartak, N.; Zhang, L.; Hagemeister, F.; Samaniego, F.; Westin, J.; Ju Lee, H.; Nastoupil, L.; Iyer, S.; Parmar, S.; Ok, C.; Kanagal‐Shamanna, R.; Chen, W.; Thirumurthi, S.; Santos, D.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. COMPREHENSIVE ANALYSIS OF PROGNOSTIC FACTORS, OUTCOMES AND MUTATION PROFILE IN PATIENTS WITH AGGRESSIVE HISTOLOGY (BLASTOID/PLEOMORPHIC) OR TRANSFORMED MANTLE CELL LYMPHOMA. (12th June 2019)

Authors:
Jain, P.; Kanagal‐Shamanna, R.; Zhang, S.; Ok, C.; Nogueras Gonzalez, G.; Gonzalez‐Pagan, O.; Ghorab, A.; Boddu, P.; Chen, W.; Lee, H. Ju; Nomie, K.; Fayad, L.; Westin, J.; Nastoupil, L.; Patel, K.; Ahmed, S.; Iyer, S.P.; Parmar, S.; Champlin, R.; Neelapu, S.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
238
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Early experience of maintenance durvalumab post chemoradiation (CRT) in stage III non-small cell lung cancer (NSCLC) across West Yorkshire network: from Expanded Access Programme (EAP) to routine clinical use. (January 2020)

Authors:
Jain, P.; Murray, P.; Clarke, K.; Franks, K.; Teo, M.; Saha, A.; Chan, S.; Conn, A.; Brown, N.; Rathbone, E.
Journal:
Lung cancer
Issue:
Volume 139(2020)Supplement 1
Page Start:
S46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗